Literature DB >> 33818868

Regarding the Article by Rugo et al.

Sarah Badaoui1, Andrew Rowland1, Michael J Sorich1, Ashley M Hopkins1.   

Abstract

Year:  2021        PMID： 33818868      PMCID： PMC8265371          DOI： 10.1002/onco.13781

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  4 in total

1.  Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring.

Authors:  Dhanusha Sabanathan; Alison Zhang; Peter Fox; Sally Coulter; Val Gebski; Bavanthi Balakrishnar; Mathew Chan; Christopher Liddle; Howard Gurney
Journal:  Cancer Chemother Pharmacol       Date:  2017-06-30       Impact factor: 3.333

2.  Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study.

Authors:  Eric Van Cutsem; Sabine Tejpar; Dirk Vanbeckevoort; Marc Peeters; Yves Humblet; Hans Gelderblom; Jan B Vermorken; Frederic Viret; Bengt Glimelius; Elisa Gallerani; Alain Hendlisz; Annemieke Cats; Markus Moehler; Xavier Sagaert; Soetkin Vlassak; Michael Schlichting; Fortunato Ciardiello
Journal:  J Clin Oncol       Date:  2012-07-02       Impact factor: 44.544

3.  Early treatment-related neutropenia predicts response to palbociclib.

Authors:  Nicholas P McAndrew; Mark A Dickson; Amy S Clark; Andrea B Troxel; Mark H O'Hara; Christopher Colameco; Maryann Gallager; Kristi Gramlich; Kelly Zafman; David Vaughn; Gary K Schwartz; Peter J O'Dwyer; Angela DeMichele
Journal:  Br J Cancer       Date:  2020-07-09       Impact factor: 9.075

4.  Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3.

Authors:  Hope S Rugo; Jens Huober; José A García-Sáenz; Norikazu Masuda; Joo Hyuk Sohn; Valerie A M Andre; Susana Barriga; Joanne Cox; Matthew Goetz
Journal:  Oncologist       Date:  2020-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.